Profiel
Peder Møller Andersen currently works at Biosergen AB, as Chief Medical Officer from 2024.
Dr. Andersen also formerly worked at Biosergen AS, as Chief Executive Officer & Director, Forward Pharma GmbH, as Managing Director from 2009 to 2016, Astion Pharma A, as Vice President-Clinical Development from 2010 to 2012, and Forward Pharma A, as Chief Operating Officer in 2017.
Dr. Andersen received his doctorate degree in 1981 from the University of Copenhagen.
Actieve functies van Peder Andersen
| Bedrijven | Functie | Begin |
|---|---|---|
| BIOSERGEN AB | Hoofd Techniek/Wetenschap/O&O | 31-01-2024 |
Eerdere bekende functies van Peder Andersen
| Bedrijven | Functie | Einde |
|---|---|---|
| FORWARD PHARMA A/S | Algemeen Directeur | 01-03-2017 |
Forward Pharma GmbH
Forward Pharma GmbH Miscellaneous Commercial ServicesCommercial Services Engages in researching and developing biotechnology | Algemeen Directeur | 01-01-2016 |
Astion Pharma A/S
Astion Pharma A/S Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Hoofd Techniek/Wetenschap/O&O | 01-01-2012 |
Biosergen AS
Biosergen AS BiotechnologyHealth Technology Operates as a biotechnology company which develops antifungal drugs for the treatment of severe invasive fungal infections | Algemeen Directeur | - |
Opleiding van Peder Andersen
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 6 |
|---|---|
Astion Pharma A/S
Astion Pharma A/S Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
University of Copenhagen
University of Copenhagen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Forward Pharma A/S
Forward Pharma A/S Pharmaceuticals: MajorHealth Technology Develops and manufactures proprietary formulations for inflammatory and neurological indications | Health Technology |
Biosergen AS
Biosergen AS BiotechnologyHealth Technology Operates as a biotechnology company which develops antifungal drugs for the treatment of severe invasive fungal infections | Health Technology |
Forward Pharma GmbH
Forward Pharma GmbH Miscellaneous Commercial ServicesCommercial Services Engages in researching and developing biotechnology | Commercial Services |
Biosergen AB
Biosergen AB BiotechnologyHealth Technology Operates as a biotechnology company that develops antifungal drugs | Health Technology |
















